| The tumour microenvironment as an integrated framework to understand cancer biology R Burgos-Panadero, F Lucantoni, E Gamero-Sandemetrio, ... Cancer Letters 461, 112-122, 2019 | 75 | 2019 |
| BCL2 and BCL (X) L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose F Lucantoni, H Düssmann, I Llorente-Folch, JHM Prehn Oncotarget 9 (40), 26046, 2018 | 46 | 2018 |
| Metabolic targeting of breast cancer cells with the 2-deoxy-D-glucose and the mitochondrial bioenergetics inhibitor MDIVI-1 F Lucantoni, H Dussmann, JHM Prehn Frontiers in Cell and Developmental Biology 6, 113, 2018 | 46 | 2018 |
| Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells F Lucantoni, AU Lindner, N O’Donovan, H Düssmann, JHM Prehn Cell death & disease 9 (2), 42, 2018 | 45 | 2018 |
| Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet? F Lucantoni, A Martínez‐Cerezuela, A Gruevska, ÁB Moragrega, ... The Journal of pathology 254 (3), 216-228, 2021 | 36 | 2021 |
| Integrating the tumor microenvironment into cancer therapy S Sanegre, F Lucantoni, R Burgos-Panadero, L de La Cruz-Merino, ... Cancers 12 (6), 1677, 2020 | 31 | 2020 |
| BCL (X) L and BCL2 increase the metabolic fitness of breast cancer cells: a single-cell imaging study F Lucantoni, M Salvucci, H Düssmann, AU Lindner, D Lambrechts, ... Cell Death & Differentiation 28 (5), 1512-1531, 2021 | 25 | 2021 |
| Peptides derived from the transmembrane domain of Bcl-2 proteins as potential mitochondrial priming tools V Andreu-Fernandez, A Genoves, TH Lee, M Stellato, F Lucantoni, ... ACS chemical biology 9 (8), 1799-1811, 2014 | 20 | 2014 |
| Low cleaved caspase-7 levels indicate unfavourable outcome across all breast cancers AU Lindner, F Lucantoni, D Varešlija, A Resler, BM Murphy, ... Journal of Molecular Medicine 96, 1025-1037, 2018 | 11 | 2018 |
| Implementing systems modelling and molecular imaging to predict the efficacy of BCL-2 inhibition in colorectal cancer patient-derived xenograft models AC O’Farrell, MA Jarzabek, AU Lindner, S Carberry, E Conroy, IS Miller, ... Cancers 12 (10), 2978, 2020 | 10 | 2020 |
| BCL (X) L and BCL2 increase mitochondrial dynamics in breast cancer cell: Evidence from functional and genetic studies F Lucantoni, M Salvucci, H Dussmann, JHM Prehn Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1868 (10), 119095, 2021 | 7 | 2021 |
| Fluorescent styrylpyrylium probes for the imaging of mitochondria in live cells IM Resta, F Lucantoni, N Apostolova, F Galindo Organic & Biomolecular Chemistry 19 (41), 9043-9057, 2021 | 6 | 2021 |
| Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less F Lucantoni, AM Benedicto, A Gruevska, ÁB Moragrega, I Fuster-Martínez, ... Cell Death & Disease 13 (4), 385, 2022 | 5 | 2022 |
| Mislocalization of Mitochondrial Intermembrane Space Proteins L Flanagan, F Lucantoni, JHM Prehn Mitochondria and Cell Death, 45-67, 2016 | 1 | 2016 |
| Rilpivirine-induced anti-inflammatory effects in non-alcoholic fatty liver disease involve the inhibition of CCL2/CCR2 axis ÁB MORAGREGA, A Gruevska, I Fuster-Martinez, AM BENEDICTO, ... JOURNAL OF HEPATOLOGY 75, S595-S595, 2021 | | 2021 |
| The hepatoprotective role of the antiretroviral drug Rilpivirine is associated with altered autophagy in in vitro and in vivo models of liver fibrosis F Lucantoni, AB BENDICTO, A GRUEVSKA, AB MORAGREGA, ... JOURNAL OF HEPATOLOGY 75, S401-S401, 2021 | | 2021 |
| An integral view of cancer (III). Evaluation of new biomarkers and treatment strategies R Noguera, R Burgos-Panadero, F Lucantoni, L de la Cruz-Merino, ... Revista Espanola de Patologia: Publicacion Oficial de la Sociedad Espanola …, 2019 | | 2019 |
| High expression of BAD, PUMA, BOK and TRADD mRNA is associated with higher overall survival in ER plus and PR plus breast cancer patients AU Lindner, F Lucantoni, D Vareslija, A Resler, WM Gallagher, A Hill, ... CANCER RESEARCH 78 (4), 2018 | | 2018 |
| BCL2 family proteins interactions as prognostic marker and determinants of therapy responses in breast cancer F Lucantoni | | 2017 |
| System-based BCL2 family protein signatures as predictive biomarkers in triple-negative breast cancer F Lucantoni, AU Lindner, N O’Donovan, D Vareslija, L Hudson, ADK Hill, ... Cancer Research 76 (14_Supplement), 3557-3557, 2016 | | 2016 |
Professor William M. GallagherUCD Conway Institute, University College DublinVerified email at ucd.ie
